Cargando…
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification
ETHNOPHARMACOLOGICAL RELEVANCE: Since the occurrence of coronavirus disease 2019 (COVID-19) in Wuhan, China in December 2019, COVID-19 has been quickly spreading out to other provinces and countries. Considering that traditional Chinese medicine (TCM) played an important role during outbreak of SARS...
Autores principales: | Li, Yuan, Chu, Fuhao, Li, Ping, Johnson, Nadia, Li, Tao, Wang, Yan, An, Rongxian, Wu, Dantong, Chen, Jiena, Su, Zeqi, Gu, Xiaohong, Ding, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835541/ https://www.ncbi.nlm.nih.gov/pubmed/33513419 http://dx.doi.org/10.1016/j.jep.2021.113854 |
Ejemplares similares
-
Manpixiao Decoction Halted the Malignant Transformation of Precancerous Lesions of Gastric Cancer: From Network Prediction to In-Vivo Verification
por: Li, Yuan, et al.
Publicado: (2022) -
Maxing Shigan Decoction Mitigates Mycoplasma pneumonia-Induced Pyroptosis in A549 Cells via the NLRP3 Inflammasome
por: Liu, Fang, et al.
Publicado: (2021) -
Application of Jiawei Maxing Shigan Tang in the treatment of COVID-19: An observational study
por: Wu, Jia, et al.
Publicado: (2022) -
Efficacy and safety of Maxing Shigan Decoction in the treatment of chronic obstructive pulmonary disease: A protocol for a systematic review and meta-analysis
por: Chen, Jinyun, et al.
Publicado: (2020) -
PPM1A as a key target of the application of Jiawei-Maxing-Shigan decoction for the attenuation of radiation-induced epithelial-mesenchymal transition in type II alveolar epithelial cells
por: Lu, Jinhua, et al.
Publicado: (2021)